跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BISOPROLOL TABLETS - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
BISOPROLOL TABLETS
Authorized
STANDARD
BISOPROLOL TABLETS
sivem pharmaceuticals ulc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
a6dca0bd5c6428aa
Company
sivem pharmaceuticals ulc
Type
Standard
Approval Details
Approval Id
a6dca0bd5c6428aa
Drug Approval Canada Name
BISOPROLOL TABLETS
Product Name
BISOPROLOL TABLETS
Status
Marketed
Status Date
2024-12-24
Original Market Date
2020-05-26
Din
02495562
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
24:24.00
Atc Original
C07AB07 BISOPROLOL
Atc Name
c 07 ab 07
Aig Number
0122418001
Company Name
sivem pharmaceuticals ulc
Company Address
4705 Dobrin Street, Saint-Laurent, Quebec, Canada, H4R 2P7
Active Ingredients
BISOPROLOL FUMARATE
5 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
a6dca0bd5c6428aa
Type
Standard
Back to Health Canada Approvals